None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Among the pediatric asthma patients built in 2016-2018 who can be tracked 2. 11–23 years of age who have asthma symptoms (whirring, dyspnea, or chronic/repetitive cough) in the last 12 months and satisfy bronchodilator response = 12% (based on baseline FEV1 levels) or PC20 methacholine = 16 mg/mL or PD15 mannitol = 635 mg
Exclusion criteria
Exclusion criteria: 1. Among the patients currently visiting the Department of Pediatrics at Asan Medical Center in Seoul, subjects aged 11-23 without childhood asthma or allergic diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bronchial potential for asthma | — |
Secondary
| Measure | Time frame |
|---|---|
| pulmonary function | — |
Countries
Korea, Republic of
Contacts
University of Ulsan